Robafen Dm (dextromethorphan Hbr recalls
The FDA has published 1 recall involving Robafen Dm (dextromethorphan Hbr since 2019. The latest was reported on 19 Jun 2019. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2019
Last 12 months0reported
Class I00% of total
Ongoing0latest 19 Jun 2019
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why robafen dm (dextromethorphan hbr is recalled
Companies
By year
All robafen dm (dextromethorphan hbr recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Robafen DM Syrup (Dextromethorphan HBr, USP 20 mg recalled | Torrent Pharma | Sterility | Nationwide |
Should you stop taking Robafen Dm (dextromethorphan Hbr?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.